Entacapone
10 NDCs across 10 manufacturers|10 Generic,0 Brand
Entacapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 19, 1999, and the first generic was approved Jul 16, 2012. FDA's Orange Book lists 8 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $20 million on Entacapone across 129,000 claims for 26,000 beneficiaries.
Entacapone is available as 10 NDCs from 10 manufacturers (10 generic, 0 brand), with NADAC prices from $0.32 to $0.41 per EA — a 27% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
10G / 0B
Manufacturers
10
competing in market
Price Spread
$0.32 – $0.41
per EA
7d Activity
avg -3.2% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Sun Pharmaceutical Industries Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Catechol-O-Methyltransferase Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
10 manufacturers producing ENTACAPONE(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ENTACAPONE 200 MG TABLET | $0.4113 per EA | — |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
ENTACAPONE 200 MG TABLET | $0.3246 per EA | -3.22% |
Frequently Asked Questions
What is Entacapone used to treat?
Entacapone is used to treat parkinson disease, per the National Library of Medicine's MED-RT classification.
When did Entacapone become available as a generic?
FDA approved the first generic Entacapone (ANDA) on Jul 16, 2012. The Orange Book currently lists 8 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Entacapone?
In 2024, Medicare Part D spent $20 million on Entacapone across 129,000 claims for 26,000 beneficiaries.
How many Entacapone products are on the market?
The Entacapone drug market contains 10 NDCs from 10 manufacturers — 10 generic and 0 brand products.
What is the price range for Entacapone?
NADAC reference prices for Entacapone range from $0.3246 to $0.4113 per EA — a 27% difference between cheapest and most expensive.
Which manufacturers make Entacapone?
10 manufacturers list Entacapone in NADAC. Ranked by number of NDCs, the largest are Sun Pharmaceutical Industries Inc. (1), Sandoz Inc. (1), Major Pharmaceuticals (1), Ajanta Pharma USA Inc. (1), Macleods Pharmaceuticals Limited (1).
How has the price of Entacapone changed recently?
Over the past 7 days, 0 Entacapone NDCs rose and 9 fell, with a market-wide average change of -3.2%.